Concepedia

Pablo A. Jimenez

PA

Statistics

Publications

14

Citations

1K

H-Index

13

Active since

1995

Affiliations

Tris Pharma (United States)(Current)

Novartis (United States)

Novartis (Switzerland)

Caris Life Sciences (United States)

Human Genome Sciences (United States)

Pablo A. Jimenez is an author at Tris Pharma (United States) specializing in allergy, medicine, and hypersensitivity.

Publications per year

1995–2023

14

Publications

14

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE‐mediated) asthma

Philip J. Lowe, Stacey Tannenbaum, Aurélie Gautier et al. · British Journal of Clinical Pharmacology · 2009 · 164 citations · Full text

, , +17

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Thomas Werfel, Gary Layton, Michael Yeadon et al. · Journal of Allergy and Clinical Immunology · 2018 · 134 citations

, , +14

Effect of omalizumab on peripheral blood eosinophilia in allergic asthma

Marc Massanari, S.T. Holgate, William W. Busse et al. · Respiratory Medicine · 2009 · 132 citations

, , +14

Keratinocyte Growth Factor-2 Accelerates Wound Healing in Incisional Wounds

Pablo A. Jimenez, Mark A. Rampy · Journal of Surgical Research · 1999 · 131 citations

, , +11

Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation

Yuping Xia, Yanan Zhao, Jeffrey R. Marcus et al. · The Journal of Pathology · 1999 · 128 citations

, , +10

1–5 of 14